Eqon Pharmaceuticals, LLC
Publicly observedCarmel, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 5 Oct 2026 | Publicly observed |
| City / locality | Carmel | NIH RePORTER (opens in a new tab) 5 Oct 2026 | Publicly observed |
| Name | Eqon Pharmaceuticals, LLC | NIH RePORTER (opens in a new tab) 5 Oct 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | K7N4NMVHDU95 | NIH RePORTER (opens in a new tab) 5 Oct 2026 | Publicly observed |
Recorded events
- Grant30 Sept 2026Publicly observed
NIH SBIR/STTR award: PRMT5 Inhibitors as a Novel Therapy for Anti-VEGF-Sensitive and -Resistant Neovascular Age-Related Macular Degeneration
USD 233,247.00 · National Eye Institute · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.